Eventide Asset Management Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
24
- Investments
-
71
- Portfolio
-
17
- Exits
-
43
Eventide Asset Management General Information
Company Description
Founded in 2008, Eventide Asset Management is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in the healthcare, life science, technology, medical technology, pharmaceuticals, food security, energy efficiency, clean water, wastewater management, and diagnostics sectors across the United States. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.eventideinvestments.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- One International Place
- Suite 4210
- Boston, MA 02110
- United States
Eventide Asset Management Investments (71)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Prana Therapies | 26-Oct-2026 | PIPE | Drug Discovery | Clinical Trials - Phase 1 | ||
| Avere Therapeutics | 10-Aug-2026 | Drug Discovery | Generating Revenue | |||
| Obsidian Therapeutics | 03-Aug-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| AdvanCell | 15-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Leo Cancer Care | 08-Jul-2026 | Therapeutic Devices | Generating Revenue | |||
| Flare Therapeutics | 30-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Serapha Bio | 22-Jun-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| IRulya Therapeutics | 18-May-2026 | Drug Discovery | Generating Revenue | |||
| Adlai Nortye | 16-Apr-2026 | PIPE | Drug Discovery | Generating Revenue | ||
| Ovid Therapeutics | 17-Mar-2026 | PIPE | Biotechnology | Generating Revenue |
Eventide Asset Management Exits (43)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Shoreline Biosciences | 18-Aug-2026 | Out of Business | |
| Freenome | 20-Jul-2026 | ||
| VYNE Therapeutics | 27-Jun-2026 | ||
| Avalyn Pharma | 30-Apr-2026 | ||
| Kojin TX | 02-Apr-2026 | ||
| Lexeo Therapeutics | 16-Oct-2025 | ||
| Kestra Medical Technologies | 06-Mar-2025 | ||
| Beta Bionics | 29-Jan-2025 | ||
| Arch Oncology | 31-May-2024 | Out of Business | |
| Praxis (Drug Discovery) | 29-Mar-2024 | Public Investment 2nd Offering |
Eventide Asset Management Investments by Industry, Year, and Region
Eventide Asset Management Co-Investors (124)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Surveyor Capital | 4 |
|
|
||
| Catalio Capital Management |
|
|
|||
| Perceptive Advisors |
|
|
|||
| Pura Vida Investments |
|
|
|||
| Piper Sandler |
|
|
Eventide Asset Management FAQs
-
What is Eventide Asset Management?
Founded in 2008, Eventide Asset Management is a venture capital firm based in Boston, Massachusetts.
-
When was Eventide Asset Management founded?
Eventide Asset Management was founded in 2008.
-
Where is Eventide Asset Management headquartered?
Eventide Asset Management is headquartered in Boston, MA.
-
What is Eventide Asset Management's total asset value?
Eventide Asset Management has around in total assets under management.
-
How many investments has Eventide Asset Management made?
Eventide Asset Management has made 71 investments.
-
What has Eventide Asset Management invested in?
Eventide Asset Management has made numerous investments in companies like Prana Therapies, Avere Therapeutics, and Obsidian Therapeutics within the Drug Discovery industry.
-
What has Eventide Asset Management invested in recently?
Eventide Asset Management's latest investment was on 26-Oct-2026 in Prana Therapies, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process